PMV Pharmaceuticals, Inc. is a biotechnology company based in Princeton, NJ, dedicated to harnessing the power of p53 to treat cancer. With over 40 years of experience in the field, PMV takes a unique approach to restoring mutated p53 proteins, aiming to structurally correct their geometry and restore their tumor suppressing function.
Through their innovative drug discovery pipeline and ongoing clinical trials, PMV Pharmaceuticals is committed to developing novel treatments that target p53 mutations, which are found in approximately half of all human cancers. Inspired by the deep experience and diversity of their employees, PMV encourages bold thinking and seamless execution in their mission to conquer cancer.
Generated from the website